These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24713870)

  • 1. Berberine attenuates axonal transport impairment and axonopathy induced by Calyculin A in N2a cells.
    Liu X; Zhou J; Abid MD; Yan H; Huang H; Wan L; Feng Z; Chen J
    PLoS One; 2014; 9(4):e93974. PubMed ID: 24713870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin reduces the impairment of axonal transport and axonopathy induced by calyculin A.
    Xiong YF; Chen Q; Chen J; Zhou J; Wang HX
    J Pineal Res; 2011 Apr; 50(3):319-27. PubMed ID: 21244478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Berberine attenuates calyculin A-induced cytotoxicity and Tau hyperphosphorylation in HEK293 cells.
    Yu G; Li Y; Tian Q; Liu R; Wang Q; Wang JZ; Wang X
    J Alzheimers Dis; 2011; 24(3):525-35. PubMed ID: 21297267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of melatonin on calyculin A-induced tau hyperphosphorylation.
    Li XC; Wang ZF; Zhang JX; Wang Q; Wang JZ
    Eur J Pharmacol; 2005 Mar; 510(1-2):25-30. PubMed ID: 15740721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin ameliorates Alzheimer-like pathological changes and spatial memory retention impairment induced by calyculin A.
    Yang X; Yang Y; Fu Z; Li Y; Feng J; Luo J; Zhang Q; Wang Q; Tian Q
    J Psychopharmacol; 2011 Aug; 25(8):1118-25. PubMed ID: 20542922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Berberine Alleviates Tau Hyperphosphorylation and Axonopathy-Associated with Diabetic Encephalopathy via Restoring PI3K/Akt/GSK3β Pathway.
    Wang S; He B; Hang W; Wu N; Xia L; Wang X; Zhang Q; Zhou X; Feng Z; Chen Q; Chen J
    J Alzheimers Dis; 2018; 65(4):1385-1400. PubMed ID: 30175975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuron-Specific Apolipoprotein E4 (1-272) Fragment Induces Tau Hyperphosphorylation and Axonopathy via Triggering Endoplasmic Reticulum Stress.
    Liang T; Xue F; Hang W; Wen B; Zhang Q; Chen J; Liu X; Chen J
    J Alzheimers Dis; 2019; 71(2):597-611. PubMed ID: 31424401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of protein phosphatases induces transport deficits and axonopathy.
    Yang Y; Yang XF; Wang YP; Tian Q; Wang XC; Li HL; Wang Q; Wang JZ
    J Neurochem; 2007 Aug; 102(3):878-86. PubMed ID: 17472709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dehydroevodiamine attenuates calyculin A-induced tau hyperphosphorylation in rat brain slices.
    Fang J; Liu R; Tian Q; Hong XP; Wang SH; Cao FY; Pan XP; Wang JZ
    Acta Pharmacol Sin; 2007 Nov; 28(11):1717-23. PubMed ID: 17959021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of cdk5/p25 in N2a cells leads to hyperphosphorylation and impaired axonal transport of neurofilament proteins.
    Zhou J; Wang H; Feng Y; Chen J
    Life Sci; 2010 Mar; 86(13-14):532-7. PubMed ID: 20153752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Berberine attenuates cognitive impairment and ameliorates tau hyperphosphorylation by limiting the self-perpetuating pathogenic cycle between NF-κB signaling, oxidative stress and neuroinflammation.
    He W; Wang C; Chen Y; He Y; Cai Z
    Pharmacol Rep; 2017 Dec; 69(6):1341-1348. PubMed ID: 29132092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humanin protects cortical neurons from calyculin A-induced neurotoxicities by increasing PP2A activity and SOD.
    Zhao J; Zeng Y; Wang Y; Shi J; Zhao W; Wu B; Du H
    Int J Neurosci; 2021 Jun; 131(6):527-535. PubMed ID: 32408779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model.
    Zhang B; Yao Y; Cornec AS; Oukoloff K; James MJ; Koivula P; Trojanowski JQ; Smith AB; Lee VM; Ballatore C; Brunden KR
    Mol Neurodegener; 2018 Nov; 13(1):59. PubMed ID: 30404654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Puerarin attenuates glutamate-induced neurofilament axonal transport impairment.
    Zhou J; Wang H; Xiong Y; Li Z; Feng Y; Chen J
    J Ethnopharmacol; 2010 Oct; 132(1):150-6. PubMed ID: 20727960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine attenuates Aβ-induced neuronal damage through regulating miR-188/NOS1 in Alzheimer's disease.
    Chen M; Li L; Liu C; Song L
    Mol Cell Biochem; 2020 Nov; 474(1-2):285-294. PubMed ID: 32779043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferases.
    Kanaan NM; Morfini GA; LaPointe NE; Pigino GF; Patterson KR; Song Y; Andreadis A; Fu Y; Brady ST; Binder LI
    J Neurosci; 2011 Jul; 31(27):9858-68. PubMed ID: 21734277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
    Xie Y; Tan Y; Zheng Y; Du X; Liu Q
    J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.
    Terwel D; Dewachter I; Van Leuven F
    Neuromolecular Med; 2002; 2(2):151-65. PubMed ID: 12428809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prominent axonopathy and disruption of axonal transport in transgenic mice expressing human apolipoprotein E4 in neurons of brain and spinal cord.
    Tesseur I; Van Dorpe J; Bruynseels K; Bronfman F; Sciot R; Van Lommel A; Van Leuven F
    Am J Pathol; 2000 Nov; 157(5):1495-510. PubMed ID: 11073810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer's disease.
    Chiasseu M; Alarcon-Martinez L; Belforte N; Quintero H; Dotigny F; Destroismaisons L; Vande Velde C; Panayi F; Louis C; Di Polo A
    Mol Neurodegener; 2017 Aug; 12(1):58. PubMed ID: 28774322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.